INTRODUCTION {#sec1-1}
============

Natural products from plants are important sources of new drugs.\[[@ref1]\] The genus *Piper* (胡椒 Hú Jiāo) (Piperaceae), which contains approximately 2000 plant species distributed mainly in tropical areas,\[[@ref2]\] is a potential source of drugs based on the use of some *Piper* species in traditional medicine. For example, nearly 30 out of 60 indigenous Chinese *Piper* species are used medically.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] Our recent ethnobotanical and medicinal chemistry research focused on *Piper* plants led to the discovery of cytotoxic amides from *Piper boehmeriifolium* Wall.,\[[@ref8][@ref9][@ref10][@ref11]\] an anticancer medicine used in India.\[[@ref12]\] In China, *Piper* plants are also used in some formulae to treat cancers.\[[@ref13][@ref14]\] The present paper reviews the traditional uses and scientific evidence for *Piper* natural products as anticancer agents. We reviewed the scientific articles that were published between 1970 and 2013 from Web of Science, SciFinder, and Google Scholar. We used the following search terms: Piperaceae, *Piper*, anticancer, antitumor, cytotoxicity, and ethnobotany. No restrictions regarding the language of publication were imposed, but most of the relevant studies were published in English and Chinese. Both plant extracts and compounds were found to show good *in vitro* cytotoxic activity with concentration giving 50% inhibition (IC~50~) values less than 30 μg/ml and 4 μg/ml, respectively, and some compounds showed significant *in vivo* antitumor activity with 50% inhibition of tumor growth at concentrations less than 15 mg/kg body weight in mice.\[[@ref15]\]

*PIPER* PLANTS WITH TRADITIONAL ANTICANCER APPLICATION {#sec1-2}
======================================================

In the literature, 10 *Piper* (胡椒 Hú Jiāo) species have been reported to treat cancer or cancer-like symptoms, as summarized in [Table 1](#T1){ref-type="table"}.

###### 

List of *Piper* plants used traditionally against cancer or cancer-like symptoms

![](JTCM-4-8-g001)

In Mexico, *Piper aduncum* L. is traditionally used to treat urological problems, dermatological conditions, and skin tumors.\[[@ref15]\] Dichloromethane extracts of *P. aduncum* leaf were marginally cytotoxic to glioma (SF-268), human large cell lung carcinoma (H-460), and human breast carcinoma (MCF-7) cell lines with IC~50~ values of 23, 25, and 27 μg/ml, respectively \[[Table 2](#T2){ref-type="table"}\].\[[@ref16]\] Piperaduncin A \[27 in [Figure 1](#F1){ref-type="fig"}\] a dihydrochalcone from this plant, showed growth inhibitory activity against human nasopharynx carcinoma (KB) cells (IC~50~ = 2.3 μg/ml) \[[Table 3](#T3){ref-type="table"}\].\[[@ref17]\]

###### 

Cytotoxic crude extracts from *Piper* plants

![](JTCM-4-8-g002)

![Cytotoxic non-alkaloid constituents from *Piper* plants](JTCM-4-8-g003){#F1}

###### 

Cytotoxic principles from *Piper* plants

![](JTCM-4-8-g004)

In the Ayurvedic system of Indian medicine, the roots of *P. boehmeriifolium* Wall. and *Piper sylvaticum* Roxb. are used for their laxative, anthelmintic, and carminative properties, as well as to treat bronchitis, diseases of the spleen, and tumors.\[[@ref12]\] Recently, a cytotoxic amide alkaloid, 1-\[(9*E*)-10-(3,4-methylenedioxyphenyl)- 9-decenoyl\] pyrrolidine \[7 in [Figure 2](#F2){ref-type="fig"}\], was isolated from the whole plant of *P. boehmeriifolium*. This compound exhibited an IC~50~ of 2.7 μg/ml against human cervical carcinoma human cervix adenocarcinoma (HeLa) cells \[[Table 3](#T3){ref-type="table"}\].\[[@ref11]\] The amide alkaloid piplartine \[1 in [Figure 2](#F2){ref-type="fig"}, Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\] might be responsible for the anticancer effect of *P. sylvaticum*.\[[@ref18]\]

![Cytotoxic amide alkaloids from *Piper* plants](JTCM-4-8-g005){#F2}

###### 

Compounds from *Piper* plants with antitumor activity *in vivo*

![](JTCM-4-8-g006)

*Piper capense* L.f. is reported to treat cancer in Cameroon; however, details about its ethnomedical uses are not included in the literature references.\[[@ref19][@ref20]\] Methanolic extracts of the seed are cytotoxic toward many tumor cell lines, including human leukemic lymphoblast (CCRF-CEM; IC~50~ = 7.03 μg/ml), human acute T-lymphoblastic leukemia (CEM/ADR5000; IC~50~ = 6.56 μg/ml), human pancreatic adenocarcinoma (Mia PaCa2; IC~50~ = 8.92 μg/ml), *p*53-expressing human colon cancer cell (HCT116 *p*53^+/+^; IC~50~ = 4.64 μg/ml), *p*53-knockout human colon cancer cell (HCT116 *p*53^−^/^−^; IC~50~ = 4.62 μg/ml), human hepatocarcinoma (Hep-G2; IC~50~ = 16.07 μg/ml), human myeloid leukemia (HL-60; IC~50~ = 8.16 μg/ml), anthracycline-resistant HL-60 (HL-60AR; IC~50~ = 11.22 μg/ml), human breast carcinoma (MDA-MB-231; IC~50~ = 4.17 μg/ml), MDA-MB-231BCRP (IC~50~ = 19.45 μg/ml), human malignant glioblastoma (U87MG; IC~50~ = 13.48 μg/ml), EGFRvIII expressing glioma cells (U87MGΔEGFR; IC~50~ = 7.44 μg/ml), etc.\[[@ref19][@ref20]\] Piperine \[6 in [Figure 2](#F2){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\] might be an active constituent.\[[@ref21][@ref22]\]

A recent ethnopharmacological study in Morocco calculated the percent importance of 14 plants selected by 100 herbalists for significance against cancer. *Piper cubeba* (蓽澄茄 Bì Chéng Qié) was one of the most important plants against cancer.\[[@ref23]\] Lignans, such as (-)-cubebin, are the major constituents of *P. cubeba*.\[[@ref24]\] Research results show that the *P. cubeba* extract (P9605) and the synthetic lignan cubebin might have potential therapeutic use against prostate cancer growth by targeting multiple aspects of the androgen-signaling pathway.\[[@ref25][@ref26]\]

In Papua New Guinea, a patient with suspected cancer or other internal sores drinks the juice squeezed from heated bark of *Piper gibbilimbum* C.DC. with traditional ash salt.\[[@ref27]\] Gibbilimbols D (IC~50~ = 2.1 μg/ml) \[19 in [Table 3](#T3){ref-type="table"}\] and B (IC~50~ = 3.9 μg/ml) \[20 in [Table 3](#T3){ref-type="table"}\] from this plant are cytotoxic toward KB cells.\[[@ref28]\]

The seed of the Nigerian plant *Piper guineense* Schum and Thonn reportedly possesses anticancer properties.\[[@ref29]\] The plant is also reported to treat cancer in Cameroon.\[[@ref20]\] A methanolic extract of its seed was cytotoxic against leukemia CEM/ADR5000 cells (IC~50~ = 8.20 μg/ml).\[[@ref20]\] However, the active constituents remain unclear.

*Piper longum* L. (syn. *Piper latifolium* Forst.) is a well-known tropical food and medicinal plant. In traditional medical practice in the Cook Islands, 12 leaves of this plant and a similar number of those of *Thespesia populnea* (L.) Soland (Malvaceae) are pounded in a wooden bowl with little water and the solution is washed on the chest of a person with suspected breast cancer.\[[@ref30]\] *P. longum* is also used to treat tumors in Indian Ayurvedic medicine. Piplartine,\[[@ref18]\] cepharadione A (15), and piperolactams A (16) and B (17) are the active principles.\[[@ref31][@ref32]\]

In Thailand, the root of *Piper nigrum* L. (black pepper plant), in the form of ghee, powders, enemas, and balms, is applied to abdominal tumors. The plant can also be used to treat abdominal fullness, adenitis, cancer, cholera, cold, colic, kidney stone, and headache.\[[@ref33]\] Black pepper (黑胡椒 Hēi Hú Jiāo) is used in some formulae to treat respiratory or gastric cancers in China.\[[@ref13][@ref14]\] Piperine might be the major active principle from *P. nigrum*.\[[@ref22][@ref34]\]

In Bolivia, a reported *Piper* species known as Tudhar is used to treat uterine cancer.\[[@ref35]\] However, the scientific name of the plant was not confirmed.

EXTRACTS FROM *PIPER* PLANTS WITH CYTOTOXIC ACTIVITY *IN VITRO* {#sec1-3}
===============================================================

Many crude extracts from *Piper* (胡椒 Hú Jiāo) plants have been evaluated for *in vitro* cytotoxicity based on ethnomedical knowledge, chemotaxonomic information, or random screening. Among them, 35 extracts of 24 *Piper* species have shown inhibitory activity (IC~50~ \< 30 μg/ml) against at least one tumor cell line \[[Table 2](#T2){ref-type="table"}\]. Extracts from *P. aduncum* L., *Piper barbatum* Kunth, *Piper fragile* Benth., *Piper jacquemontianum* Kunth, and *Piper pellucidum* L. showed the highest potential against at least one tumor cell line, with an IC~50~ value less than 4 μg/ml.\[[@ref16][@ref36]\]

COMPOUNDS FROM *PIPER* PLANTS WITH CYTOTOXIC ACTIVITY *IN VITRO* {#sec1-4}
================================================================

Chemical constituents of *Piper* (胡椒 Hú Jiāo) plants mainly include amide alkaloids, phenylpropanoids, lignans, neolignans, terpenes, steroids, kawapyrones, piperolides, flavonoids, and alkenylphenols.\[[@ref9][@ref45][@ref46][@ref47]\] Thirty-two compounds (1-32) have been reported to exhibit cytotoxic activity toward at least one tumor cell line with an IC~50~ value less than 4 μg/ml \[[Table 3](#T3){ref-type="table"}\]. These compounds include amide alkaloids (1-17), a lignan (18), alkenylphenols (19-22), chalcones and dihydrochalcones (25-27), piperolides (28-31), and other chemical classifications. The amide alkaloids account for 53% of the total active principles. Chabamide G \[13 in [Figure 2](#F2){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\] and sintenpyridone \[5 in [Figure 2](#F2){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\] exhibited the most potent activity against human colon adenocarcinoma (COLO-205; IC~50~ = 0.018 μg/ml) and HT-29 (IC~50~ = 0.025 μg/ml) cell lines, respectively.\[[@ref48]\] Piplartine is the most promising compound showing toxicity against dozens of cell lines along with significant *in vivo* activity \[Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\].\[[@ref18][@ref49][@ref50][@ref51][@ref52][@ref53]\]

COMPOUNDS FROM *PIPER* PLANTS WITH ANTITUMOR ACTIVITY *IN VIVO* {#sec1-5}
===============================================================

A few *Piper* (胡椒 Hú Jiāo) compounds have been studied for *in vivo* antitumor activity. Piplartine (1) and flavokawain B \[26 in [Figure 1](#F1){ref-type="fig"}\] exhibited significant inhibitory effects on the growth of at least one tumor cell line *in vivo* at concentrations less than 15 mg/kg body weight \[[Table 4](#T4){ref-type="table"}\]. Piplartine was tested against xenograft models of human bladder carcinoma (EJ), human breast carcinoma (MDA-MB436), human alveolar carcinoma epithelial (A549), murine melanoma (B16-F10), and MMTV-polyomavirus middle T antigen transgenic mice model (MMTV-PyVT). Animals were treated for 13 or 21 days at a dose of 1.5 or 2.4 mg/kg/day. Marked antitumor effects were observed in the treated tumor-bearing mice with inhibition rates near those with positive controls, paclitaxel (10 mg/kg/day) and cisplatin (1 mg/kg/day).\[[@ref67]\] In addition, flavokawain B treatment (0.75 mg/kg/day) significantly inhibited *in vivo* growth of human KB cell-derived tumor xenografts in nude mice.\[[@ref68]\]

ANTICANCER MECHANISMS OF ACTION OF *PIPER* COMPOUNDS {#sec1-6}
====================================================

Piplartine {#sec2-1}
----------

Piplartine, also known as piperlongumine, comprises approximately 0.11% content in the fruit of *P. longum*.\[[@ref18][@ref69]\] The compound kills cancer cells by targeting the stress response to reactive oxygen species (ROS). Piplartine induces apoptosis selectively in cells that have a cancer genotype by targeting a non-oncogene co-dependency acquired through expression of the cancer genotype in response to transformation-induced oxidative stress.\[[@ref67]\] Structure-activity relationships suggest that the electrophilicity of the C2-C3 olefin is critical for the observed effects on cancer cells.\[[@ref70]\] The latest studies suggest that cancer cell lines are more resilient to chemically induced increases in ROS levels than previously thought and highlight that electrophilicity may be more closely associated with cancer-selective cell death than ROS elevation.\[[@ref71]\]

Piplartine may target p38 signaling to cause selective killing of cancer cells and autophagy.\[[@ref72][@ref73]\] Research results suggest that the anticancer activity of piplartine involves inhibition of the ubiquitin-proteasome system at a pre-proteasomal step, prior to de-ubiquitination of malfolded protein substrates at the proteasome, and that the previously reported induction of ROS is a consequence of this inhibition.\[[@ref74]\]

Piplartine can down-regulate Epstein--Barr virus encoded latent membrane protein 1 (EBV-encoded LMP1), cellular myelocytomatosis oncogene (Myc), constitutive nuclear factor kappa B (NF-κB) activity, and a host of LMP1-Myc-NF-κB-regulated target genes, while the LMP1-NF-κB-Myc axis plays the central role in B-lineage neoplasia.\[[@ref51]\] Piplartine-dependent cytotoxicity is affected in part by reduced NF-κB and Myc activity.\[[@ref50]\]

Piplartine induces rapid depletion of the androgen receptor in prostate cancer cells. Consequently, piplartine may afford novel opportunities for both prevention and treatment of prostatic malignancy.\[[@ref75]\] Piplartine may act, at least in part, on the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway to cause colon cancer cell death.\[[@ref76]\]

Piperine {#sec2-2}
--------

Piperine (6) is a major component of black (*P. nigrum*) and long (*P. longum*) pepper. The content of piperine in black pepper varies between 5% and 9%.\[[@ref77]\] Piperine can inhibit human fibrosarcoma (HT-1080) cell expression of matrix metalloproteinase (MMP)-9, thereby interfering with tumor cell migration and invasion.\[[@ref78]\] Piperine inhibits *HER2* gene expression at the transcriptional level implying that it may be a potential agent for the prevention and treatment of human breast cancer with *HER2* overexpression.\[[@ref79]\] Piperine-induced cytotoxicity against human rectal tumor (HRT)-18 cells may be mediated at least in part by ROS.\[[@ref80]\] Piperine also exhibits an antiproliferative effect on human prostate cancer cells by inducing cell cycle arrest and autophagy.\[[@ref81]\]

Flavokawain B {#sec2-3}
-------------

Kava (*Piper methysticum* Forst.) is a perennial plant indigenous to the Pacific Islands. Some data indicate that the more kava consumed by a population, the lower the cancer incidence in that population.\[[@ref82]\] Flavokawain B, constituting about 0.015% of kava extracts, appears to be a potent antiproliferative agent against a wide variety of cancer cells.\[[@ref83][@ref84]\] Flavokawain B--induced apoptosis, at least in part, requires Bim expression.\[[@ref66]\] In KB cells, the induction of apoptosis by flavokawain B may involve both the death receptor and mitochondrial pathway.\[[@ref68]\] Flavokawain B also has a pro-apoptotic effect on synovial sarcomas cell lines.\[[@ref85]\] Flavokawain B induces apoptosis of non-small cell lung cancer H-460 cells via Bax-initiated mitochondrial and c-Jun N-terminal kinase (JNK) pathways.\[[@ref86]\] In osteosarcoma cell lines, apoptotic induction by flavokawain B involves both extrinsic and intrinsic pathways. Flavokawain B also causes G2/M phase cell cycle arrest.\[[@ref64]\]

CONCLUSION {#sec1-7}
==========

*Piper* (胡椒 Hú Jiāo) plants are important sources for research on and development of new anticancer agents. Ten *Piper* plants have been used as traditional medicines to treat cancer or cancer-like symptoms. In various studies, 35 extracts from 24 *Piper* species and 32 compounds from *Piper* plants were found to possess *in vitro* cytotoxic activity. Among them, the amide alkaloid piplartine (1) represents the most promising candidate showing cytotoxicity against dozens of cell lines, together with excellent *in vivo* activity. *Piper* plants comprise about 2000 species, most of which have not been studied for their chemical constituents and anticancer effects. Thus, further *in vitro* and *in vivo* anticancer research studies on *Piper* plants and their isolates are worthwhile.

ABBREVIATIONS USED {#sec1-8}
==================

143B, human osteosarcoma; 4T1, murine mammary carcinoma; A549, human alveolar carcinoma epithelial; A2780, human ovarian carcinoma; B-16, murine melanoma; B16-F10, murine melanoma; BCRP, breast cancer resistance protein; C4-2B, human prostate cancer; CCRF-CEM, human leukemic lymphoblast; CEM, human lymphoblastic leukemia; CEM/ADR5000, human acute T-lymphoblastic leukemia; CHCl~3~, chloroform; CH~2~Cl~2~, dichloromethane; COLO-205, human colon adenocarcinoma; DU-145, human prostate carcinoma; EAT, Ehrlich ascites tumor; EBV, Epstein Barr virus; EJ, human bladder carcinoma; ERK, extracellular signal-regulated kinase; EtOH, ethanol; MCF-7, human breast carcinoma; H-460, human large cell lung carcinoma; HCT116 *p*53^+/+^, *p*53-expressing human colon cancer cell; HCT116 *p*53^−/−^, *p*53-knockout human colon cancer cell; HeLa, human cervix adenocarcinoma; HEp-2, human laryngeal carcinoma; Hep-G2, human hepatocarcinoma; IC~50~, concentration giving 50% inhibition; HL-60, human myeloid leukemia; human promyelocytic leukemia; HL-60AR, anthracycline-resistant HL-60; HRT-18, human rectal tumor; HT-1080, human fibrosarcoma; K562, human erythromyeloblastoid leukemia; KB, human nasopharynx carcinoma; LNCaP, human prostate carcinoma; MCF-7, human breast carcinoma; MDA-MB-231, human breast carcinoma; MDA-MB436, human breast carcinoma; MEK, mitogen-activated protein kinase; MeOH, methanol; Mia PaCa2, human pancreatic adenocarcinoma; MMTV-PyVT, MMTV-polyomavirus middle T antigen transgenic mice model; Molt-4, human lymphocytic leukemia; NCI-H460, human non-small cell lung cancer; NF-κB, nuclear factor kappa B; P-388, mouse lymphocytic leukemia; PC-3, human prostate adenocarcinoma; PE, petroleum ether; ROS, reactive oxygen species; SF-268, glioma; SK-LMS-1, human leiomyosarcoma; SK-MEL-2, human skin melanoma; U87MG, human malignant glioblastoma; U87MGΔEGFR, EGFRvIII expressing glioma cells; WPMY-1, human prostatic stromal myofibroblast.
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